title

Presentation 2
Mepsgen, a startup in a journey to commercialization of organ-on-a-chip technology

Speaker

김용태 YongTae Kim

Professor of Georgia Tech, Founding CEO of Mepsgen

Dr. YongTae Kim is an Associate Professor of the George W. Woodruff School of Mechanical Engineering at Georgia Institute of Technology. Dr. Kim’s research cuts across the interface of bioengineering and nanotechnology. His laboratory uses experimental and computational approaches based on mechanical and electrical engineering principles to engineer microelectromechanical systems for probing dynamic responses of biological systems at molecular, cellular, and tissue levels, and the interactions with nanomaterials. His laboratory seeks to understand (1) how cells coordinate responses to combination of signaling cues in multicellular environments; (2) how bio/nanomaterials assemble and break in dynamically controlled fluid flow; and (3) how biological systems interact with nanomaterials. Prior to his current appointment, he was a Postdoctoral Associate in the Langer Laboratory of the David H. Koch Institute for Integrative Cancer Research at MIT. He received a Ph.D. in Mechanical Engineering from Carnegie Mellon University. Before joining Carnegie Mellon, he was a researcher in areas of controls and robotics at R&D Divisions of Hyundai-Kia Motors and Samsung Electronics for 6 years. He received Bachelor’s and Master’s degrees in Mechanical Engineering from Seoul National University. He has authored multidisciplinary research articles in major journals including Nature Communications, Trends in Biotechnology, PNAS, Nano Letters, Biomaterials, ACS Nano, Nano Today, Advanced Materials, Advanced Functional Materials, JACS, Scientific Reports, PLoS ONE, Lab Chip, and Bioconjugate Chemistry. He has won NIH Director’s New Innovator Award, NSF CAREER Award, and AHA National Scientist Development Grant Award. He was selected as a distinguished panel speaker in multidisciplinary biomimetic engineering for the Annual Beckman Scholars and Young Investigators Symposium. He has filed over 23 patent applications worldwide. He has consulted for several pharmaceutical and biomedical companies regarding manufacturing of drug-loaded nanoparticles and development of organ-on-a-chip systems. He founded Mepsgen a biotechnology company that develops microengineered physiological systems with biomimetic micro- and nanoengineering innovations for advanced therapeutics development.